Certified by Founder Lodge
Xontogeny
United States - Boston, MA
INVESTOR
1 Disclosed Funding Rounds $200,000,000
3 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Xontogeny (zon-TOJ-uh-nee) is a biotech aggregator with a differentiated business model to support the accelerated development of life science technologies in the pursuit of helping patients
| Company | Date | Round | Raised |
|---|---|---|---|
 CARGO Therapeutics |
March, 06 ,2023 | Series A | $200,000,000 |
 Avalyn Pharma Inc. |
September, 28 ,2023 | Series C | $175,000,000 |
 CereVasc |
May, 14 ,2024 | Series B | $70,000,000 |
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Valinor | $13,000,000 | (Dec 12, 2025)
Double (1) | $6,500,000 | (Dec 12, 2025)
Keeper | $4,000,000 | (Dec 12, 2025)
OnCorps AI | $55,000,000 | (Dec 12, 2025)
Cyphlens | $3,800,000 | (Dec 12, 2025)
